Oncology is the branch of medicine that gives you the opportunity to touch not only the patient’s organic problem, but also his or her psyche, the person as a whole. Despite the practical difficulties of practicing oncology, ie administering complex treatments with a serious degree of toxicity and side effects, the oncologist has to give courage and hope to the patient, taking away his or her stress and agony, opening-up a new perspective for his/her life, and treating the medical problem. This constant battle requires huge mental reserves from the doctor / therapist, who must somehow find ways to replenish them, otherwise he will inevitably distance himself from the patient, and the mental bond he must have with him/her may crack and break. The relationship between the two is reciprocal and should be based on mutual trust, honesty, and undiminished interest.
Oncology is the fastest growing medical specialty, with scientific knowledge being enriched daily. Thus, the oncologist is called to be constantly informed and up-to-date with all important developments.
The effort to combine scientific knowledge with the caring and offering the best to your patients, is part of our everyday life here at the German Oncology Center, as a member of which I was invited to join the Journey and, by participating in its Interdisciplinary Team, I try with all my colleagues to provide the best possible support to each and every one of our patients.
European Society for Medical Oncology-ESMO 2018
P. Kountourakis, A. Agathocleous, E. Kakouri, Y. Marcou, G. Orphanos, F. Kyriacou, D. Papamichael.
Poster: Hepatitis screening for patients to undergo chemotherapy in Cyprus. Ann Oncol (2018) 29 (suppl_8): viii603-viii640. 10.1093/annonc/mdy300
8th International Oncology Week of the World Federation of Surgical Oncology Societies, 2017
G. Orphanos.
Oral presentation: Modern principles of Immunotherapy of Cancer
The 3rd Cyprus Oncology Conference: New frontiers in Cancer Prevention and Personalized Treatment, 2017
G. Orphanos
Oral presentation: Management of toxicity of immunotherapy
American Society of Clinical Oncology – ASCO, 2006
G. Orphanos, A. Alexopoulos, G. Ioannidis, C. Kandylis, A. Ardavanis, J. Stavrakakis, G. Rigatos.
Publication: High efficacy and low toxicity of the combination of Vinorelbine and Capecitabine as second line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines. J Clin Oncology.2006;24.18S (abstract No 10719)
American Society of Clinical Oncology – ASCO, 2005
C.J. Gallagher, G. Orphanos, M. Perianan, A. Saha, P. Wilson, R. Reznek, D. Oram A. Jeyarajah, K. Reynolds, J. Shepherd.
Poster: Treatment of women with abdominal carcinomatosis of suspected ovarian origin and prognostic importance of response to primary chemotherapy. J Clin Oncology. 2005; 23.16S: 471 (abstract No 5069)
European Society for Medical Oncology Scientific & Educational Conference ESEC, Budapest 2005
G.Ioannidis, A.Ardavanis, G.Orphanos, G.Rigatos
Poster: Salvage treatment with single agent Capecitabine in patients with heavily pretreated advanced colorectal cancer. Ann Oncology. 2005;16.S2: ii286 (abstract No 58P)
6th Central European Lung Cancer Conference, Budapest 1999
G.Koumakis, V.Barbounis, M.Vassilomanolakis, H.Hatzichristou, M.Demiri, E.Psaras, V.Kanakakis, G.Orphanos, A.Efremidis.
Phase I-II trial of weekly Paclitaxel in advanced non-small cell lung cancer (N.S.C.L.C.): a preliminary report.